chloroquinoxaline
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2000 (NCT00005864)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- DNA topoisomerase 2INHIBITOR
TOP2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- chloroquinoxaline
- chloroquinoxaline
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00008372 | Phase 2 | Dec 1, 2000 | City of Hope National Medical Center, National Cancer Institute (NCI), University of California, Davis |
| NCT00005864 | Phase 2 | Apr 1, 2000 | National Cancer Institute (NCI), Ohio State University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 2000 |
| City of Hope National Medical Center | Academic/Hospital | 1 | 1 | 1 | 2000 |
| Ohio State University | Academic/Hospital | 1 | 1 | 1 | 2000 |
| University of California, Davis | Academic/Hospital | 1 | 0 | 1 | 2000 |
4 organizations
Page 1 / 1